In the past, it was believed that most malabsorptive diseases manifested with diarrhea, steatorrhea, or both. It is now recognized that many malabsorptive disorders, such as celiac disease, might have subtle clinical presentations or mainly extraintestinal manifestations (e.g., anemia, bone loss, menstrual disturbance) that lead to a delayed and/or erroneous diagnosis. Awareness is also increasing that subtle malabsorption of single nutrients such as calcium or vitamin B 12 can, if unrecognized, lead to complications that may be difficult to reverse or that are even irreversible. The clinical challenge today is to recognize and treat malabsorption despite its subtle manifestations, a challenge made even more difficult by the restricted availability of tests for malabsorption, such as the 72-hour fecal fat determination.

Classically, maldigestion is defined as defective intraluminal hydrolysis of nutrients, and malabsorption is defined as defective mucosal absorption. Although this distinction may be useful on pathophysiologic grounds, the clinical presentation and complications of maldigestion and malabsorption are similar. Moreover, physiologic processes other than digestion and absorption (e.g., solubilization, intestinal motility, hormone secretion) contribute to the normal absorption of nutrients, vitamins, and minerals, so the classic definitions of maldigestion and malabsorption do not cover the actual pathophysiologic spectrum of the malabsorption syndrome. In this chapter, the terms digestion and absorption or maldigestion and malabsorption are used separately only in the discussion of pathophysiology. When the distinction between these terms is not of clinical relevance, only the terms absorption and malabsorption are used.

Malabsorption can be caused by many diseases of the small intestine as well as by diseases of the pancreas, liver, biliary tract, and stomach ( Box 104.1 ). In some of these diseases, malabsorption may be the presenting feature; in others, malabsorption may be only a minor clinical problem or detected only as a laboratory abnormality.

BOX 104.1
Diseases That Cause Nutrient Malabsorption

Gastric Diseases

  • Atrophic gastritis

  • Autoimmune gastritis (pernicious anemia)

  • Gastric resection or bypass surgery

Pancreatic Diseases

  • Congenital pancreatic enzyme deficiencies

    • Co-lipase deficiency

    • Lipase deficiency

    • Trypsinogen deficiency

  • Pancreatic insufficiency

    • Chronic pancreatitis

    • Cystic fibrosis

    • Johanson-Blizzard syndrome

    • Pearson marrow-pancreas syndrome

    • Shwachman syndrome

  • Pancreatic tumors

Liver Diseases

  • Inborn errors of bile acid biosynthesis and transport

  • Cirrhosis and other liver diseases

  • Portal hypertension

Obstructive Biliary Diseases

  • Biliary tumors

  • Primary and secondary sclerosing cholangitis

Intestinal Diseases

  • Amyloidosis

  • Autoimmune enteropathy

  • Celiac disease

  • Collagenous sprue

  • Congenital intestinal defects (see Table 104.10 )

  • Crohn disease

  • Enteroendocrine cell deficiency

    • Autoimmune Polyendocrinopathy, Candidiasis, EctodermalDystrophy (APECED)

    • Enteric anendocrinosis

  • Enterokinase deficiency

  • Eosinophilic gastroenteritis

  • Fistulas

  • Food allergy

  • Graft-versus-host disease

  • Hypolactasia

  • Ileal bile acid malabsorption

  • Intestinal infections

    • AIDS (HIV infection): cryptosporidiosis, Mycobacterium avium complex infection, viral infections

    • Giardiasis

    • Helminthic infections

    • Tuberculosis

    • Whipple disease

  • Immunoproliferative small intestinal disease

  • Intestinal ischemia

  • Intestinal lymphoma

  • Intestinal resections or bypass

  • Mastocytosis

  • Nongranulomatous chronic idiopathic enterocolitis

  • Postinfection malabsorption

  • Primary immunodeficiency diseases

  • Radiation enteritis

  • Refractory sprue

  • Sarcoidosis

  • SIBO

  • Tropical sprue

Lymphatic Diseases

  • Primary intestinal lymphangiectasia

  • Secondary intestinal lymphangiectasia

    • Lymphoma

    • Solid tumors

    • Thoracic duct trauma, damage, or obstruction

Neuroendocrine Tumors

  • Carcinoid syndrome

  • Gastrinoma (ZES)

  • Glucagonoma

  • Somatostatinoma

Cardiovascular Diseases

  • Constrictive pericarditis

  • Heart failure

Endocrine Diseases

  • Addison disease

  • Diabetes mellitus

  • Hyperthyroidism

Systemic Diseases

  • Cronkhite-Canada syndrome

  • Mixed connective tissue disease

  • Neurofibromatosis type 1

  • Protein-calorie malnutrition

  • Scleroderma

  • SLE

This chapter provides an overview of basic pathophysiologic mechanisms that lead to symptoms or complications of maldigestion or malabsorption, reviews the clinical manifestations and complications of malabsorption, describes tests that can be used clinically to evaluate digestive and absorptive function, presents a rational diagnostic approach to the individual patient, and discusses malabsorptive diseases and general measures in the treatment of malabsorption syndrome not covered in other chapters of this book.

Etiology and Pathophysiology

From a pathophysiologic point of view, mechanisms that cause malabsorption can be divided into pre-mucosal (luminal), mucosal, and postmucosal (vascular and lymphatic) factors. For clinical purposes, this approach is of limited value because the various clinical pictures caused by malabsorption syndromes are determined mainly by the nature of the malabsorbed substrates. We, therefore, discuss the mechanisms causing malabsorption based on the malabsorbed substrate. A separate section is devoted to the role of mechanisms that compensate for the consequences of malabsorption.

Normal uptake of nutrients, vitamins, and minerals by the GI tract (see Chapters 102 and 103 ) requires several steps, each of which can be compromised in disease.

Solubilization is a prerequisite for absorption of such nutrients as fat or calcium. Fat and fat-soluble vitamins are solubilized by the formation of micelles, and calcium is solubilized through acidification in the GI lumen. Alternatively, increased solubilization of the components of intestinal chyme can contribute to the manifestations of GI diseases, such as increased absorption of oxalate, which can result in the development of kidney stones in patients with short bowel syndrome (see Chapter 106 ).

Digestion of macromolecular compounds such as polysaccharides, triglycerides, and proteins to their molecular components—monosaccharides, fatty acids, and amino acids (AAs), respectively—is achieved by soluble or membrane-bound digestive enzymes. Absorption of undigested or partially digested macromolecular compounds occurs to a very minor degree in health and may be increased slightly in various intestinal diseases. Although such absorption does not play a nutritive role, it may be important for the normal function of the immune system and the pathogenesis of diseases such as food allergy (see Chapter 10 ).

Liberation of substrate (e.g., vitamin B 12 ) from binding sites in food or, conversely, binding to factors such as intrinsic factor (IF) allows absorption to take place.

Chemical changes to nutrients may be required for absorption, such as reducing the charge of iron from Fe +3 to Fe +2 .

Mucosal absorption can occur by active or passive carrier-mediated transport or simple or facilitated diffusion (see Chapter 101 ). Postmucosal transport of absorbed substrates occurs in blood vessels and lymphatic vessels.

Intestinal sensory and motor function permits detection of the presence of nutrients, facilitates adequate mixing of nutrients with intestinal secretions and delivery to absorptive sites, and provides adequate time for nutrient absorption (see Chapter 99 ).

Neural and hormonal functions are required to stimulate and coordinate digestive secretions, mucosal absorption, and intestinal motility (see Chapters 4 and 99 ).

An overview of pathophysiologic mechanisms of maldigestion and malabsorption is provided in Table 104.1 . This table also shows the ingested substrates primarily affected by individual pathophysiologic mechanisms and lists examples of etiologic disorders for these mechanisms.

TABLE 104.1
Mechanisms of Malabsorption, Malabsorbed Substrates, and Representative Causes
Pathophysiologic Mechanism Malabsorbed Substrate(s) Representative Causes
Maldigestion
Conjugated bile acid deficiency Fat
Fat-soluble vitamins
Calcium
Magnesium
Hepatic parenchymal disease
Biliary obstruction
SIBO with bile acid deconjugation
Ileal bile acid malabsorption
CCK deficiency
Pancreatic insufficiency Fat
Protein
Carbohydrate
Fat-soluble vitamins
Vitamin B 12 (cobalamin)
Congenital defects
Chronic pancreatitis
Pancreatic tumors
Inactivation of pancreatic enzymes (e.g., ZES)
Reduced mucosal digestion Carbohydrate Congenital defects (see Table 104.10 )
Acquired lactase deficiency
Protein Generalized mucosal disease (e.g., celiac disease, Crohn disease)
Intraluminal consumption of nutrients Vitamin B 12 (cobalamin) SIBO
Helminthic infections (e.g., Diphyllobothrium latum infection)
Malabsorption
Reduced mucosal absorption Fat
Protein
Carbohydrate
Vitamins
Minerals
Congenital transport defects (see Table 104.10 )
Generalized mucosal diseases (e.g., celiac disease, Crohn disease)
Previous intestinal resection or bypass
Infections
Intestinal lymphoma
Decreased transport from the intestine Fat
Protein
Intestinal lymphangiectasia

  • Primary

  • Secondary (e.g., solid tumors, Whipple disease, lymphomas)

Venous stasis (e.g., from heart failure)

Other Mechanisms
Decreased gastric acid and/or intrinsic factor secretion Vitamin B 12 Pernicious anemia
Atrophic gastritis
Previous gastric resection
Decreased gastric mixing and/or rapid gastric emptying Fat
Calcium
Protein
Previous gastric resection
Autonomic neuropathy
Rapid intestinal transit Fat Autonomic neuropathy
Hyperthyroidism

Fats

Defective Mixing

For sufficient digestion and absorption of lipids, dietary fat must adequately mix with digestive secretions. Gastric resections or GI motility disorders that result in rapid gastric emptying or rapid intestinal transit, such as autonomic neuropathy due to diabetes mellitus or amyloidosis, can cause fat malabsorption consequent to impaired GI mixing of dietary fat.

Reduced Solubilization of Fat

Fat malabsorption resulting from decreased formation of micelles occurs if the luminal concentrations of conjugated bile acids (BAs) are lower than the critical concentration required for forming micelles. Table 104.2 details the pathophysiologic mechanisms and representative diseases that cause luminal BA deficiency.

TABLE 104.2
Pathophysiologic Mechanisms That Result in Deficiency of Luminal Conjugated Bile Acids
Pathophysiologic Mechanism Causes
Decreased synthesis and/or secretion of conjugated bile acids Parenchymal liver diseases (e.g., cirrhosis, PBC)
Biliary obstruction (e.g., tumors)
Biliary fistulas
Inborn errors of bile acid synthesis
CCK deficiency
Intestinal loss of conjugated bile acids Ileal resection
Severe ileal mucosal disease
Congenital defects of the ileal sodium-bile acid co-transporter
Luminal deconjugation of bile acids SIBO
Binding of bile salts or lack of solubilization of bile salts as a result of low luminal pH Cholestyramine (binding)
ZES (low pH)
Exocrine pancreatic insufficiency (low pH)

Decreased Lipolysis

If exocrine pancreatic function is severely reduced, impairment of pancreatic lipase and co-lipase secretion results in decreased luminal hydrolysis of dietary fat. Chronic pancreatitis, cystic fibrosis, pancreatic duct obstruction by pancreatic and ampullary tumors, and pancreatic resection are the most common causes of pancreatic insufficiency. Even when pancreatic enzyme concentrations are normal, reduced pancreatic lipase activity resulting from low luminal pH, excessive calcium ingestion, or ingestion of the specific lipase inhibitor orlistat can cause pancreatic steatorrhea. Selective congenital lipase or co-lipase deficiency is a rare cause of pancreatic fat malabsorption.

Decreased Mucosal Absorption and Chylomicron Formation

Generalized mucosal diseases such as celiac disease are often associated with fat malabsorption. Defective uptake of free fatty acids and monoglycerides results from reduced mucosal surface area secondary to villus shortening, reduced enterocyte function, and mucosal inflammation. Intestinal fat absorption is also impaired in diseases that result in disturbance of intracellular formation of chylomicrons and accumulation of lipids within the enterocytes, including abetalipoproteinemia, hypobetalipoproteinemia, and chylomicron retention disease.

Defective Lymphatic Transport of Chylomicrons

Impairment of lymphatic transport of chylomicrons is a cause for postmucosal malabsorption of dietary fat. Decreased lymphatic transport can result from congenital diseases such as primary intestinal lymphangiectasia or from obstruction of lymphatic vessels as a result of metastatic solid tumors, lymphoma, Whipple disease, retroperitoneal fibrosis, or trauma (see Chapter 31 ). Usually, lymphatic vessels in the mucosa become dilated (lymphangiectasia), and chylomicrons are lost post-prandially into the intestinal lumen and also in the fasting state ; steatorrhea in these situations usually is only mild to moderate.

Proteins and Amino Acids

Defective digestion or absorption of dietary proteins has to be differentiated from excessive loss of serum proteins into the GI tract, which is termed protein-losing enteropathy (see Chapter 31 ).

Defective Intraluminal Proteolysis

Protein digestion may be impaired in patients who have undergone partial or total gastric resection, presumably as a result of poor mixing with digestive secretions, although gastric pepsin deficiency could be contributory. Impaired activation of pepsin due to acid inhibition by PPIs can result in an increased risk of food allergy with manifestations such as childhood asthma, owing to decreased gastric digestion of proteins (see Chapter 10 ). Defective proteolysis also occurs with exocrine pancreatic insufficiency. In congenital diseases, pancreatic proteolysis can be impaired by inborn errors in the synthesis of proteolytic enzymes (trypsinogen deficiency) or by defective activation of pancreatic proenzymes resulting from congenital deficiency of intestinal enterokinase (see Congenital Defects).

Defective Mucosal Hydrolysis of Peptides and Decreased Absorption of Oligopeptides and Amino Acids

Generalized mucosal diseases, such as celiac disease, result in global malabsorption, which includes malabsorption of oligopeptides and AAs secondary to lack of mucosal hydrolysis of oligopeptides and defective mucosal absorption. Reduction of intestinal absorptive surface, as in short bowel syndrome (see Chapter 106 ) or jejunoileal bypass, also results in protein and AA malabsorption. Congenital defects of AA transporters on the enterocytes (e.g., Hartnup disease, lysinuric protein intolerance) can lead to selective malabsorption of a subgroup of AAs (see Chapter 102 and see Congenital Defects).

Carbohydrates

The pathophysiologic mechanisms and clinical role of carbohydrate malabsorption has been recently reviewed.

Defective Intraluminal Hydrolysis of Carbohydrates

Pancreatic α-amylase is normally secreted in excess into the intestinal lumen. In mild forms of pancreatic insufficiency, carbohydrate digestion usually is at least partially preserved, but severe pancreatic insufficiency results in clinically apparent carbohydrate malabsorption and diarrhea due to decreased luminal hydrolysis of ingested starch.

Mucosal Defects of Carbohydrate Digestion and Absorption

The most common cause of carbohydrate malabsorption is late-onset lactose malabsorption due to decreased levels of the intestinal brush border enzyme lactase (adult-type hypolactasia, acquired primary lactase deficiency). Depending on ethnic background, lactase is present in less than 5% to greater than 90% of the adult population; its deficiency results in a selective malabsorption of lactose. Acquired malabsorption of carbohydrates occurs commonly after extensive intestinal resections, in diffuse mucosal diseases such as celiac or Crohn disease, or temporarily after self-limited GI infections (postinfection carbohydrate malabsorption). The pathophysiologic mechanisms of carbohydrate malabsorption are reduction of the intestinal mucosal surface area and reduced activity or expression of intestinal oligo- and disaccharidases or transport proteins for monosaccharides. Congenital disaccharidase deficiencies (lactase, sucrase-isomaltase, trehalase) and congenital deficiency or malfunction of transport molecules, as in congenital glucose-galactose malabsorption, can cause early onset of malabsorption of mono- or disaccharides (see Congential Defects). Intolerance of fructose is discussed in a subsequent section.

Vitamins

Fat-Soluble Vitamins

Diseases that cause malabsorption of dietary fat commonly cause malabsorption of fat-soluble vitamins because they require similar absorptive mechanisms. This is especially relevant in diseases that result in impaired micelle formation because of bile salt deficiency. Fat-soluble vitamins also are malabsorbed in diffuse diseases of the mucosal surface area, in diseases affecting chylomicron formation and transport, and in exocrine pancreatic insufficiency. Some authors have suggested that absorption of fat-soluble vitamins is less affected by exocrine pancreatic insufficiency than by small intestinal diseases with resultant steatorrhea. Genetic defects of BA conjugation may also result in malabsorption of fat-soluble vitamins.

Water-Soluble Vitamins

Vitamin B 12 (cobalamin)

Decreased release of dietary vitamin B 12 from food sources because of impaired pepsin and acid secretion, as in atrophic gastritis or with use of gastric acid inhibitors, usually results in only mild cobalamin malabsorption without clinical consequences. By contrast, deficiency of gastric IF secretion, as occurs in pernicious anemia (PA) or after gastric resections, or secretion of an abnormal IF, as in some congenital diseases, results in severe vitamin B 12 malabsorption with clinical consequences.

Autoimmune gastritis seen with PA is the most common cause of vitamin B 12 malabsorption (see Chapter 52 ). Cobalamin malabsorption in PA is caused by decreased IF secretion, which results from parietal cell destruction and by the production of blocking autoantibodies that inhibit binding of IF to vitamin B 12 . Mild cobalamin malabsorption may be found in patients with ZES (see Chapter 34 ) and in patients with pancreatic insufficiency (see Chapter 59 ), owing to decreased proteolytic release of vitamin B 12 from its complex with R-binding protein (see Chapter 103Chapter 103Chapter 34 ).

In SIBO (see Chapter 105 ) or helminthic infection with Diphyllobothrium latum (see Chapter 114 ), dietary cobalamin is made unavailable to the host and is, therefore, unavailable for intestinal absorption.

Diseases and conditions that affect the ileal mucosa (e.g., Crohn disease, ileal resection) lead to a reduction of specific absorptive sites for the IF-vitamin B 12 complex. Ileal resections of more than 30 cm bear the risk of clinically significant vitamin B 12 malabsorption. Imerslund-Gräsbeck syndrome, a disease of autosomal recessive inheritance due to abnormalities of the cubilin-amnionless complex, is characterized by selective ileal malabsorption of the IF-vitamin B 12 complex despite normal ileal morphology (see Chapter 103 ). Congenital diseases affecting transcobalamin II also result in malabsorption of cobalamin.

In previously healthy persons, it usually takes several years of vitamin B 12 malabsorption before cobalamin deficiency develops, because hepatic stores contain large amounts of cobalamin and the daily requirement is relatively small.

Folate

Folate malabsorption occurs with mucosal diseases that affect the proximal small intestine, such as celiac disease and Whipple disease. Folate deficiency is common in chronic alcoholuse, where it is postulated to be caused by decreased dietary intake as well as decreased intestinal absorption of folate. As discussed later, several drugs may result in impaired intestinal uptake of folate and an inherited form of selective folate malabsorption has been described. In contrast to cobalamin, body stores of folate are small relative to daily requirements; hence folate deficiency develops much faster (i.e., within weeks) than cobalamin deficiency in the setting of malabsorption. Increased serum folate levels resulting from bacterial production of tetrahydrofolate have been reported in SIBO.

Other Water-Soluble Vitamins

Other water-soluble vitamins, such as ascorbic acid and the B-complex vitamins, are absorbed in the small intestine either by carrier-mediated transport or passive diffusion (see Chapter 103 ). Generalized malabsorption syndromes from intestinal causes impair the absorption of these vitamins, thereby leading to deficiency states. Deficiency of water-soluble vitamins also occurs with chronic alcoholuse, probably owing to decreased oral intake and reduced intestinal absorption.

Minerals

Calcium

Severe calcium malabsorption can occur in diseases that affect the small intestinal mucosa (e.g., celiac disease) and luminal malabsorption (e.g., exocrine pancreatic insufficiency), and has been shown to result in low-trauma fractures. In these disease states, calcium absorption is impaired directly because of the reduction of the intestinal surface area (celiac disease) and indirectly because of formation of insoluble calcium soaps with malabsorbed long-chain fatty acids (pancreatic insufficiency). Diseases that cause malabsorption of long-chain fatty acids by other mechanisms, such as bile acid deficiency, can also result in calcium malabsorption. In many of these diseases, malabsorption and deficiency of vitamin D further contribute to intestinal calcium malabsorption. Selective intestinal malabsorption of calcium (i.e., without fat malabsorption) can occur in renal disease, hypoparathyroidism, and inborn defects in formation of 1α,25-dihydroxyvitamin D or in the intestinal vitamin D receptor. Calcium malabsorption also commonly occurs after gastric resection (see “Malabsorption after Gastric Resection” [later]). Dosage of PPIs and duration of gastric acid suppression are associated with increased risk of hip fractures, presumably due in part to decreased or impaired absorption of dietary calcium, although both the magnitude and exact explanation of risk are controversial.

Magnesium

In many generalized malabsorptive disorders, magnesium deficiency due to magnesium malabsorption results from a reduction in mucosal absorptive surface area and luminal binding of magnesium by malabsorbed fatty acids. A congenital form of selective intestinal magnesium malabsorption has also been reported.

Iron

Iron deficiency is common in patients with gastric resection or celiac disease. Also, achlorhydria may result in iron deficiency because the absorption of iron in these patients is less than the physiologic iron losses, a phenomenon which is not overcome by the adaptive increase in duodenal iron absorption that occurs in response to iron deficiency. Reduction in the mucosal surface area of the small intestine as a result of diffuse mucosal disease, intestinal resection, or intestinal bypass can result in impaired iron absorption, potentially leading to iron deficiency. A congenital form of iron malabsorption has also been described (see Table 104.10 ). Intestinal loss of iron from chronic GI bleeding is, however, the most common GI cause of iron deficiency. Hookworm infection is the most common cause of iron deficiency worldwide (see Chapter 114 ).

TABLE 104.10
Congenital Disorders of the Gastrointestinal Mucosa That Result in Malabsorption
Disorder Causative Gene Suggested Mode of Inheritance Malabsorbed Substrate(s) Suggested Mechanism of Malabsorption Clinical Features Reference(s)
Malabsorption of Amino Acids
Hartnup disorder
OMIM# 234500
SLC6A19 AR Neutral amino acids (tryptophan, leucine, methionine, phenylalanine, tyrosine, valine, ?histidine, ?lysine) Decreased intestinal absorption of free neutral amino acids Most patients are asymptomatic; some patients have photosensitive skin rash, intermittent ataxia, psychotic behavior, mental retardation, diarrhea
Cystinuria (types A, B, AB)
OMIM# 220100
Type A: SLC3A1
Type B: SLC7A9
AR (type A) and incomplete AR (type B) Cystine and/or dibasic amino acids (lysine, ornithine, arginine) Decreased intestinal absorption of specific free amino acids owing to a defective amino acid transporter at the brush border membrane
Type A: no transport of cystine, lysine, or arginine
Type B: reduced or normal cystine transport and reduced or no lysine and arginine transport
Aminoaciduria, cystine stones in the urinary tract
Lysinuric protein intolerance
OMIM# 222700
SLC7A7 AR Dibasic amino acids (lysine, ornithine, arginine) Defect of the basolateral transporter (y+LAT-1) for dibasic amino acids (also malabsorption of di- and oligopeptides) Sparse hair, hyperammonemia, nausea, vomiting, diarrhea, protein malnutrition, failure to thrive, aversion to protein-rich food
Isolated lysinuria ? ? Lysine Decreased intestinal absorption of lysine Mental retardation, malnutrition, failure to thrive
Iminoglycinuria
OMIM# 242600
SLC6A20
SLC6A19
SLC36A2
AR l-Proline Impaired intestinal absorption of l-proline in a subgroup of subjects Aminoaciduria; benign disorder
Blue diaper syndrome
OMIM# 211000
? AR Tryptophan Intestinal tryptophan absorption defect Blue discoloration of diapers, failure to thrive, hypercalcemia, nephrocalcinosis
Methionine malabsorption syndrome (Oasthouse syndrome)
OMIM# 250900
? AR Methionine Intestinal methionine absorption defect Mental retardation, convulsions, diarrhea, white hair, hyperpnea; urine has characteristic sweet smell of dried celery
Lowe oculocerebral syndrome
OMIM# 30900
OCRL1 XR Lysine, arginine Impaired intestinal lysine and arginine absorption Aminoaciduria, mental retardation, cataracts, rickets, choreoathetosis, renal disease
Malabsorption of Carbohydrates
Congenital lactase deficiency
OMIM# 22300
LCT AR Lactose Permanent very low lactase activity Diarrhea, bloating, and dehydration in the first days of life
Sucrase-isomaltase deficiency
OMIM# 2229000
SI AR Sucrose, starch Sucrase activity is absent; isomaltase activity is absent or reduced; reduced maltase activity Osmotic diarrhea after starch or sucrose ingestion; failure to thrive ,
Trehalase deficiency
OMIM# 612119
TREH AR Trehalose Lack of intestinal trehalase activity Diarrhea and/or vomiting after ingesting mushrooms
Glucose-galactose malabsorption
OMIM# 606824
SLC5A1 AR Glucose, galactose Defect of the brush border sodium-glucose cotransporter (SGLT1) Neonatal onset of osmotic diarrhea, dehydration, intermittent or constant glycosuria
Malabsorption of Fat
Abetalipoproteinemia
OMIM# 200100
MTP AR Fat, fat-soluble vitamins Defective lipoprotein assembly owing to a lack of MTP, resulting in TG accumulation in the enterocyte and no chylomicron formation Steatorrhea, diarrhea, neurologic symptoms, retinitis pigmentosa, failure to thrive, absence of chylomicrons and VLDL in the blood, acanthocytosis
Familial hypobetalipoproteinemia
OMIM# 615558
APOB Incomplete AD Fat, fat-soluble vitamins TG accumulation in the enterocyte in homozygotes owing to formation of a truncated apolipoprotein B Homozygotes: clinical manifestations as for abetalipoproteinemia
Heterozygotes: fat absorption probably normal; hypolipidemia, neurologic manifestations
Chylomicron retention disease SAR1B AR Fat Defective chylomicron formation and accumulation in the enterocyte Steatorrhea, failure to thrive, absence of chylomicrons and reduced LDL levels in the blood; neurologic symptoms in some patients ,
(Anderson disease)
OMIM# 246700
Cholesteryl ester storage disease (Wolman disease)
OMIM# 278000
LIPA AR Fat Deficient activity of hLAL, cholesteryl ester hydrolase, causing accumulation of cholesteryl esters and TGs in various body tissues; infiltration of intestinal mucosa with foamy cells, intestinal damage Steatorrhea, hepatosplenomegaly, abdominal distention; failure to thrive, adrenal calcifications ,
Malabsorption of Vitamins
Congenital IF deficiency (congenital pernicious anemia)
OMIM# 261000
GIF AR Cobalamin (vitamin B 12 ) Defective synthesis of IF or synthesis of an abnormal IF with either reduced affinity for cobalamin or for the ileal IF receptor, or increased susceptibility to proteolysis Megaloblastic anemia, neurologic symptoms, delayed development
Imerslund-Gräsbeck syndrome (ileal B 12 malabsorption, megaloblastic anemia type I)
OMIM# 261100
CUBN or AMN AR Cobalamin (vitamin B 12 ) Impaired ileal absorption of IF-cobalamin complex owing to defects in the cubilin-AMN complex (IF-cobalamin receptor) Megaloblastic anemia, neurologic symptoms, proteinuria ,
Transcobalamin II deficiency
OMIM# 275350
TCN2 AR Cobalamin (vitamin B 12 ) Defective transport of cobalamin out of enterocytes into the portal blood owing to absence or malfunction of transcobalamin II Vomiting, diarrhea, failure to thrive, anemia, immunodeficiency, neurologic symptoms ,
Hereditary folate malabsorption
OMIM# 229050
SLC46A1 AR Folate Defective folate transport across the intestinal mucosa Megaloblastic anemia, diarrhea, neurologic symptoms
Malabsorption of Minerals
Acrodermatitis enteropathica
OMIM# 201100
SLC39A4 AR Zinc Defective zinc absorption in the small intestine owing to a defect in the zinc transport protein (hZIP4) Diarrhea, scaling erythematous dermatitis, alopecia, neuropsychiatric symptoms; onset after weaning
Isolated magnesium malabsorption (hypomagnesemia with secondary hypocalcemia [HOMG])
OMIM# 602014
TRPM6 AR Magnesium Selective defect in intestinal magnesium absorption Tetany, convulsion, diarrhea, hypomagnesemia with secondary hypocalcemia
Menkes disease
OMIM# 309400
ATP7A XR Copper General copper transport disorder; intestinal copper malabsorption with copper accumulation in the intestinal mucosa owing to a defective transmembrane copper-transporting ATPase (MNK) Cerebral degeneration, diarrhea, abnormal hair, hypopigmentation, arterial rupture, thrombosis, hypothermia, bone changes
Occipital horn syndrome (X-linked cutis laxa)
OMIM# 304150
ATP7A XR Copper Milder form of same defect as in Menkes disease; low levels of functional MNK Inguinal hernias, bladder and ureteral diverticula, skin and joint laxity, chronic diarrhea, bone changes
Iron-refractory iron-deficient anemia
OMIM# 206200
TMPRSS6 AR Iron Intestinal iron transport disorder Iron-deficient anemia that is unresponsive to oral iron supplementation
Hereditary selective deficiency of 1α,25(OH) 2 D (pseudo–vitamin D deficiency rickets)
OMIM# 264700
CYP27B1 AR Calcium Defective 25(OH)D 1α-hydroxylase, resulting in 1α,25(OH) 2 D deficiency and reduced intestinal calcium absorption Bone pain, deformities and fractures, muscle weakness
Hereditary generalized resistance to 1α,25(OH) 2 D (vitamin D-resistant rickets)
OMIM# 277440
VDR AR Calcium Malfunction of the vitamin D receptor owing to defective hormone binding, defective receptor translocation to nucleus, or defective receptor binding to DNA, resulting in malabsorption of calcium Bone pain, deformities and fractures, muscle weakness, alopecia
Other Defects
Enterokinase deficiency
OMIM# 226200
PRSS7 AR Protein, fat Defective activation of pancreatic proenzymes owing to lack of intestinal enterokinase Diarrhea, failure to thrive, hypoproteinemia, edema, anemia ,
Congenital bile acid malabsorption
OMIM# 613291
SLC10A2 AR Bile acids, fat Defect of the ileal ASBT Steatorrhea, diarrhea, failure to thrive
Microvillus inclusion disease
OMIM# 251850
MYO5B AR Carbohydrates, fat, cobalamin, electrolytes, water Villus atrophy with microvillus inclusions in enterocytes, absent or shortened brush border microvilli Severe watery diarrhea and steatorrhea requiring total parenteral nutrition
Hyperinsulinism, with enteropathy and deafness
OMIM# 606528
USH1C, ABCC8, or KCNJ11 AR Generalized malabsorption Enteropathy with villus atrophy and inflammation Hyperinsulinism, profound congenital sensorineural deafness, enteropathy, renal tubular dysfunction
Immune dysregulation polyendocrinopathy and enteropathy, X-linked (IPEX)
OMIM# 304790
FOXP3 XR Generalized malabsorption Villus atrophy Polyendocrinopathies, severe diarrhea, hemolytic anemia
Enteric anendocrinosis
OMIM# 610370
NEUROG3 AR Generalized malabsorption Lack of enteroendocrine cells Severe diarrhea, failure to thrive, type 1 diabetes mellitus
Congenital proprotein convertase 1/3 deficiency
OMIM# 600955
PCSK1 AR Generalized malabsorption Lack of functional hormone production by enteroendocrine cells Severe diarrhea, polyendocrinopathies, failure to thrive, overweight in later age
Congenital tufting enteropathy
OMIM# 613217
EpCAM AR Generalized malabsorption Intestinal epithelial cell dysplasia and villus atrophy Severe diarrhea, failure to thrive
CHAPLE syndrome
CD55deficiency with hyperactivation of complement,
angiopathic thrombosis, and protein-losing enteropathy
OMIM# 226300
CD55 AR Protein losing enteropathy, vitamin and micronutrient deficiencies Intestinal lymphangiectasia Anemia, growth retardation, diarrhea, abdominal pain, hypoproteinemia, thrombosis
% sign (in place of #) means that the gene causing the disease is unknown in this case.
AD , autosomal dominant; AMN , amnionless; AR , autosomal recessive; ASBT , sodium bile acid co-transporter; CUBN , cubilin; hLAL , human lysosomal acid lipase; IF , intrinsic factor; LDL , low-density lipoprotein; MTP , microsomal TG transfer protein; 1α,25(OH) 2 D , 1α,25-dihydroxyvitamin D; 25(OH)D , 25-hydroxyvitamin D; VLDL , very-low-density lipoprotein; XR , X-linked recessive.

Reported in only a few cases.

Zinc

Zinc, like other minerals, is malabsorbed in generalized mucosal diseases of the small intestine. A congenital selective defect of zinc absorption, acrodermatitis enteropathica, is caused by a defect in the zinc transport protein hZIP4 (see Table 104.10 ).

Others

Generalized malabsorption can cause deficiency of copper and selenium. In Menkes disease (kinky hair disease), an inherited disorder of cellular copper transport, selective intestinal copper malabsorption results (see later). It is uncertain whether malabsorptive diseases result in deficiencies of chromium and manganese.

Mechanisms that Compensate for Malabsorption

Role of the Colon

The colon has the capacity to absorb a limited number but wide variety of substances and nutrients, including sodium, chloride, water, oxalate, short-chain fatty acids, calcium, water-soluble vitamins (biotin, folate, pantothenic acid [B 5 ], pyridoxine [B 6 ], riboflavin [B 2 ], thiamine [B 1 ]), and vitamin K (see Chapter 103 ). Although colonic nutrient absorption plays a lesser role in health, the nutritive role of the colon in patients with severe malabsorption is clinically relevant. Colonic salvage of malabsorbed nutrients can also result in symptoms and complications such as colonic hyperabsorption of oxalate, which contributes to the formation of renal stones (see later).

The role of the colon in the pathogenesis of symptoms related to lactose malabsorption and incomplete fructose absorption (fructose malabsorption), such as bloating, abdominal cramps, and diarrhea, is unclear. A discrepancy between malabsorption, as demonstrated by hydrogen breath testing (HBT), and these intolerance symptoms have been demonstrated in adults and children.

Colonic Salvage of Incompletely Absorbed Carbohydrates

In healthy people, between 2% and 20% of ingested starch escapes absorption in the small intestine; pancreatic insufficiency or severe intestinal disorders further increase this amount. Carbohydrates that reach the colon cannot be absorbed by the colonic mucosa but can be metabolized by colonic bacteria. Metabolism by anaerobic bacteria results in breakdown of oligosaccharides and polysaccharides to mono- and disaccharides, which are further metabolized to lactic acid, short-chain (C2 to C4) fatty acids (SCFAs; e.g., acetate, propionate, butyrate), and odorless gases (e.g., hydrogen, methane, carbon dioxide).

Studies in normal subjects have suggested that bacterial metabolism of starch to small carbohydrate moieties is a rapid process in the normal colon. The rate-limiting step in the overall conversion of polysaccharides to SCFAs appears to be the conversion of monosaccharides to SCFAs. Colonic absorption of SCFAs results in the reduction of the osmotic load and, as a result, mitigation of osmotic diarrhea. In normal subjects, more than 45 g of carbohydrates must reach the colon to cause diarrhea, and up to 80 g of carbohydrates per day can be metabolized by bacteria to SCFAs; approximately 90% of these SCFAs are absorbed by colonic mucosa ( Fig. 104.1 ). Chronic carbohydrate malabsorption causes adaptive changes in bacterial metabolic activity that result in even higher efficiency of the bacterial microbiota to digest carbohydrates, but at the expense of increased flatus production.

Fig. 104.1, Carbohydrate metabolism and absorption of metabolic products in the colon.

Because SCFAs have caloric values between 3.4 and 5.95 kcal/g, their colonic absorption can contribute positively to overall calorie balance. In patients with short bowel syndrome, colonic salvage of malabsorbed carbohydrates can save up to 700 to 950 kcal/day, provided a substantial part of the colon remains in continuity with the small intestine (see Chapter 106 ). Not all SCFAs are absorbed by the colon, and those not absorbed contribute to osmotic diarrhea.

The benefits of colonic bacterial carbohydrate metabolism may be offset by side effects due to gas production (see Chapter 17 ). Up to 10-fold differences in the volume of gas produced in the colon have been observed in normal persons. The colon also can absorb gas, and if intracolonic gas volumes are low, up to 90% of the volume of intracolonic gas can be absorbed; if gas volumes are high, however, this proportion can decrease to 20% ( Fig. 104.2 ). Therefore persons who have the disadvantage of producing more gas in their colons have an additional disadvantage of absorbing a smaller fraction of the gas. Gas produced from bacterial carbohydrate metabolism is odorless. The odor of flatus is due to volatile sulfur-containing substrates that result from bacterial metabolism of protein.

Fig. 104.2, Relationship between flatus volume and colonic hydrogen absorption during fasting (open circles) and after ingestion of 12.5 g of lactose (closed circles) . At high flatus volumes, the fraction of hydrogen excreted in breath decreases to about 20% of total hydrogen excretion; the remaining 80% is excreted in flatus.

Impaired colonic salvage of carbohydrates has been suggested to contribute to the diarrhea in Crohn disease and UC. Bacterial carbohydrate metabolism may be lessened by antibiotic treatment. In some patients, antibiotic-associated diarrhea may be the result of impaired colonic salvage of carbohydrates or the result of dietary fiber that can accumulate in stool because of decreased bacterial fermentation.

Role of the Colon in Fat Malabsorption

Long-chain triglycerides or fatty acids, which constitute most dietary fat, cannot be absorbed by the human colon. Long-chain fatty acids bind calcium in the colon, thereby increasing the amount of oxalate that is absorbed bound to sodium. Fatty acids with chain lengths longer than 12 carbons can cause diarrhea because they increase mucosal permeability and inhibit colonic absorption of fluid and electrolytes. An increase in colonic permeability due to long-chain fatty acids also may be a contributing factor for the increased colonic oxalate absorption seen in patients with steatorrhea and hyperoxaluria.

Patients with short bowel syndrome can gain caloric energy from colonic absorption of medium-chain fatty acids coming from medium-chain triglyceride supplementation if they have at least part of the colon in continuity with the remaining small intestine.

Colonic Salvage of Calcium

Although most unabsorbed calcium is insoluble when it reaches the terminal ileum, preservation of at least half of the colon in patients with extensive small bowel resection improves calcium absorption by about 40%, compared with calcium absorption in patients who have an ileostomy. Absorption of calcium requires solubilization of calcium salts. Bacterial metabolism of dietary fiber or incompletely absorbed carbohydrates can help solubilize calcium by causing a decrease in the pH of luminal contents in the colon. Once calcium is solubilized, it can contact the cecal mucosa, which, in the rat, has the highest calcium absorption rate per surface area of intestine. Calcium solubilization in the colon from bacterial fermentation of malabsorbed lactose can also occur in patients with lactose malabsorption; in this condition, the bioavailability of calcium from milk is greater than that from mineral water. In addition to their effect on luminal pH, the SCFAs, such as acetate and propionate, which are products of bacterial metabolism of lactose, have been shown to directly enhance calcium absorption in the human colon.

Role of Intestinal Transit in the Salvage of Malabsorbed Nutrients

The lower parts of the GI tract do not normally contact nutrients, but upon doing so, intestinal transit time becomes prolonged. This delay in transit could contribute to compensatory mechanisms in malabsorptive diseases, although nutritional salvage by this mechanism has not been quantitated. SCFAs prolong colonic transit time and, hence, increase the contact time of liminal contents with the colonic mucosa.

Clinical Features and Evaluation

Malabsorption usually is suspected on the basis of the patient’s history, signs and symptoms, or findings on routine laboratory evaluations. Malabsorption of an ingested nutrient or substrate can be confirmed by measuring its increased stool concentration, its decreased serum concentration, or its urinary excretion. Finding the cause of malabsorption often requires tests such as endoscopy with small intestinal biopsy; under certain clinical circumstances, noninvasive tests or radiologic imaging are helpful in providing a specific diagnosis.

Suspecting and Confirming the Presence of Malabsorption

History and Physical Examination

Table 104.3 lists symptoms and signs suggestive of malabsorption, although virtually all can have causes other than malabsorption. For example, greasy stools might indicate malabsorption, but a greasy appearance also can be caused by mucus in the stool. Floating of stool in the toilet water can be due to a high stool fat content, but it can also be caused by high gas content. Nevertheless, such symptoms and signs are helpful in raising the clinician’s index of suspicion for malabsorption and in guiding the choice of which specific laboratory tests, structural evaluations, or function tests should be ordered.

TABLE 104.3
Symptoms and Signs of Malabsorption and Relevant Pathophysiology
Symptom or Sign Pathophysiologic Explanation
Cutaneous and Mucosal
Acrodermatitis, scaly dermatitis Deficiency of zinc and essential fatty acids
Easy bruisability, ecchymoses, petechiae Deficiency of vitamin K, vitamin C (scurvy)
Edema Protein loss or malabsorption
Follicular hyperkeratosis Deficiency of vitamin A
Glossitis, cheilosis, stomatitis Deficiency of vitamin B complex, vitamin B 12 , folate, or iron
Hyperpigmented dermatitis Deficiency of niacin (pellagra)
Perifollicular hemorrhage Malabsorption of vitamin C
Spiral or curly hair Malabsorption of vitamin C
Thin nails with spoon-shaped deformity Deficiency of iron
Gastrointestinal
Abdominal distention, flatulence Gas production from bacterial fermentation of carbohydrates in the colon, SIBO
Ascites Protein loss or malabsorption
Diarrhea Osmotic activity of carbohydrates or short-chain fatty acids
Secretory effect of bile acids and fatty acids
Decreased absorptive surface
Intestinal loss of conjugated bile acids:
  • Ileal resection

  • Severe ileal mucosal disease

  • Congenital defects of the ileal sodium-bile acid co-transporter

Foul-smelling flatulence or stool Malabsorption of proteins or intestinal protein loss
Pain Gaseous distention of the intestine
Musculoskeletal
Bone pain, osteomalacia, fractures Protein, calcium, or vitamin D deficiency; secondary hyperparathyroidism
Tetany, muscle weakness, paresthesias Malabsorption of vitamin D, calcium, magnesium, and phosphate
Other
Amenorrhea, impotence, infertility Multifactorial (including protein malabsorption, secondary hypopituitarism, anemia)
Anemia Deficiency of iron, folate, or vitamin B 12
Fatigue, weakness Calorie depletion, iron and folate deficiency, anemia
Growth and weight retardation, infantilism Nutrient malabsorption in childhood and adolescence
Kidney stones Increased colonic oxalate absorption
Night blindness, xerophthalmia Deficiency of vitamin A
Neurologic symptoms, ataxia Deficiency of vitamin B 12 , vitamin E, or folate
Peripheral neuropathy Deficiency of vitamin B 12 or thiamine
Weight loss, hyperphagia Nutrient malabsorption

The current obesity epidemic has led to a changing picture of malabsorption; for example, few patients today with celiac disease are underweight at diagnosis, and some are even overweight. These patients have been reported to be less likely to present with classic features such as diarrhea or anemia, and further weight gain after dietary gluten exclusion may be a cause of increased morbidity.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here